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Parkinson’s disease (PD) is the second most common
neurodegenerative disorder after Alzheimer disease and
affects up to 2% of individuals after the age 65. It is
characterized by progressive motor decline and loss of
dopaminergic neurons from the substantia nigra (SN)
leading resting tremor, rigidity, bradykinesia and postural
instability. Differential characteristics of PD pathology is
the loss of dopaminergic neurons and the presence of
intracellular protein aggregates. The etiology of the dis-
ease is still unknown and it is likely due to a multifactor-
ial interaction of genes and the environmental factors on
the background of ageing.
The impact of enzyme activities, gene expressions and
genetic polymorphisms in GSTs on PD has received parti-
cular interest since these enzymes play an important role
in the detoxification and metabolism of several environ-
mental chemicals and xenobiotics which may be asso-
ciated to PD. Patients with idiopathic PD appear to have
reduced capacity for detoxification and/or metabolism of
certain environmental compounds such as cigarette smoke
and pesticides.
Therefore we aimed to examine GST theta, mu, pi and
total GST activities by the use of ENPP, EAA, DCNB and
CDNB as substrates, respectively in a MPTP induced ani-
mal (mouse) model of Parkinson’s disease. In the same
animal model we also investigated the gene expression
levels of GSTM1 and GSTP1 using the method of qPCR.
As a result, we observed an increase in cytosolic GST
teta (GSTT) and cytosolic total GST activity which are sta-
tistically significant. qPCR results indicated an significant
increase for GSTP1 mRNA expression level.
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